Feb 23 (Reuters) - AstraZeneca Plc expects its
COVID-19 vaccine could receive U.S. Emergency Use Authorization
at the beginning of April and could immediately deliver 30
million doses of the shot there, a top executive said at a
hearing in the U.S. House of Representatives on Tuesday.
Ruud Dobber, executive vice president at AstraZeneca, said
that the drugmaker expects to be able to deliver 50 million
doses of the vaccine by the end of April.
(Reporting by Michael Erman)